Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,335,475
+$4,971,094 QoQ
Shares Held
237,216
+3.5% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 497 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. ARWR ranks #24 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in ARWR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,335,475 | 237,216 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $14,364,381 | 229,097 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $26,244,696 | 395,311 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $13,326,037 | 386,374 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,435,987 | 407,341 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,033,751 | 395,114 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,611,112 | 245,272 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,684,536 | 241,845 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $6,261,406 | 240,916 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $7,837,829 | 274,050 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $8,434,491 | 275,637 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $5,870,288 | 218,470 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,951,288 | 222,975 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,889,320 | 231,863 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $11,330,070 | 279,341 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $8,830,067 | 267,173 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,464,341 | 268,797 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $11,757,021 | 255,643 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,096,907 | 227,706 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $13,987,127 | 224,045 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,624,871 | 200,735 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $19,145,817 | 288,732 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,165,541 | 249,779 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $10,418,926 | 241,963 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,536,372 | 243,954 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,030,762 | 140,103 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||